FDA NDC Directory · JSON-LD · Markdown

Symvess

NDC 83564-110 · HUMAN PRESCRIPTION DRUG · IMPLANT

Generic nameACELLULAR TISSUE ENGINEERED VESSEL
Labeler / ManufacturerHumacyte Global, Inc.
Marketing categoryBiologic License Application · App BLA125812
Dosage form / routeIMPLANT · INTRAVASCULAR
Active ingredientsACELLULAR TISSUE ENGINEERED VESSEL (420 mm/1)
Marketing started20241219
Package count1

External sources

Source: openFDA. Public-domain (CC0).